American Oriental Bioengineering, Inc.Beijing China
Company Description
American Oriental Bioengineering (AOBO) is firmly planted in the pharmaceutical industry. Through subsidiaries, AOBO makes more than 90 plant-based pharmaceuticals and nutraceuticals based on Traditional Chinese Medicine (TCM). Its products (primarily sold in China) include prescription and over-the-counter herbal and vitamin beverages, pills, gels, patches, and powders to treat a variety of ailments from bedwetting to respiratory diseases. It sells directly to retail stores, pharmacies, hospitals, and independent distributors who act as resellers. AOBO, which was founded in 1970, operates about 30 offices throughout China. CEO Tony Liu has a controlling ownership stake (about 40%) in the company.
| 1 Liangshuihe First Ave., Beijing E-Town Economic And Technology Development Area, E-Town | Phone: +86-10-5982-2039 | http://www.bioaobo.com |
| Beijing 100176 | Fax: 201-200-9928 | |
| China |
American Oriental Bioengineering, Inc. Rankings
Executives
| 10 executives listed for American Oriental Bioengineering, Inc.'s Beijing, China location. | ||
| Chairman and CEO | Shujun Liu | |
|---|---|---|
| CFO and Director | Yanchun Li | |
| Chief Accounting Officer and Director | Binsheng Li | |
Financials
| Company Type | Public - NYSE: AOB |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 4,295 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on American Oriental Bioengineering, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
